Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 56.80
-1.75 (-2.99%)
At close: Apr 23, 2025, 2:57 PM CST
SHE:301033 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Net Income | 68.26 | 40.88 | 35.73 | 44.71 | 36.97 | 27.68 | Upgrade
|
| Depreciation & Amortization | 24.95 | 24.95 | 15.16 | 8.19 | 5.04 | 4.35 | Upgrade
|
| Other Amortization | 1.6 | 1.6 | 1.35 | 1.46 | 1.39 | 1.66 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.17 | -0.01 | -0.08 | 0.17 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.22 | 0.22 | 1.25 | 0.01 | 0.29 | 0.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.69 | -3.69 | -7.99 | -7.08 | -5.29 | -6.22 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.04 | 0.04 | 0.03 | -0.05 | 0.05 | 0 | Upgrade
|
| Other Operating Activities | -33.13 | 2.21 | -1.93 | 1.1 | 0.64 | -0.2 | Upgrade
|
| Change in Accounts Receivable | -7.14 | -7.14 | -6.78 | 2.2 | -3.94 | 2.43 | Upgrade
|
| Change in Inventory | 3.19 | 3.19 | -8.27 | -4.64 | -1.01 | -6.7 | Upgrade
|
| Change in Accounts Payable | 43.8 | 43.8 | 16.18 | 17.92 | -2.06 | 5.16 | Upgrade
|
| Change in Other Net Operating Assets | 5.44 | 5.44 | -0.2 | - | - | - | Upgrade
|
| Operating Cash Flow | 99.72 | 107.69 | 48.31 | 66.51 | 33.91 | 31.27 | Upgrade
|
| Operating Cash Flow Growth | 12.57% | 122.91% | -27.37% | 96.15% | 8.43% | 442.82% | Upgrade
|
| Capital Expenditures | -35.07 | -40.09 | -135.96 | -152.71 | -61.65 | -36.71 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.03 | 0.06 | 0.01 | 0.1 | 0.14 | Upgrade
|
| Investment in Securities | 21.51 | -41.84 | 157.9 | -162.23 | -36.2 | -61.2 | Upgrade
|
| Other Investing Activities | -0.2 | - | -3.45 | - | 5.98 | 5.44 | Upgrade
|
| Investing Cash Flow | -13.75 | -81.9 | 18.55 | -314.93 | -91.77 | -92.32 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 54.12 | 47.45 | - | Upgrade
|
| Long-Term Debt Repaid | - | -28.62 | -27.18 | -2.77 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -53.45 | -28.62 | -27.18 | 51.34 | 47.45 | - | Upgrade
|
| Issuance of Common Stock | 9.31 | - | - | 250.05 | - | - | Upgrade
|
| Common Dividends Paid | -27.19 | -15.28 | -8.05 | - | - | - | Upgrade
|
| Other Financing Activities | -11.66 | - | - | -53.9 | -5.96 | -0.28 | Upgrade
|
| Financing Cash Flow | -82.99 | -43.9 | -35.23 | 247.49 | 41.49 | -0.28 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | 0.02 | 2.97 | -0.42 | -0.33 | 0.12 | Upgrade
|
| Net Cash Flow | 2.95 | -18.09 | 34.61 | -1.35 | -16.7 | -61.21 | Upgrade
|
| Free Cash Flow | 64.65 | 67.6 | -87.65 | -86.2 | -27.74 | -5.44 | Upgrade
|
| Free Cash Flow Margin | 23.42% | 29.28% | -44.89% | -56.05% | -22.46% | -4.80% | Upgrade
|
| Free Cash Flow Per Share | 0.99 | 1.02 | -1.32 | -1.52 | -0.56 | -0.11 | Upgrade
|
| Cash Income Tax Paid | 34.27 | 19.36 | 6.68 | 4.13 | 8.09 | 10.61 | Upgrade
|
| Levered Free Cash Flow | -31.99 | 17.89 | -118 | -127.14 | -26.65 | -13.71 | Upgrade
|
| Unlevered Free Cash Flow | -31.1 | 19.27 | -116.88 | -126.83 | -26.65 | -13.71 | Upgrade
|
| Change in Net Working Capital | 70.1 | -5.18 | 13.52 | 0.64 | -12.56 | -9.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.